Tauroursodeoxycholate counteracts hepatocellular lysis induced by tensioactive bile salts by preventing plasma membrane-micelle transition

Chemico-Biological Interactions

Volumn 188, Issue 3, 2010, Pages 386-392

  Basiglio, Cecilia L ^a   Mottino, Aldo D ^a   Roma, Marcelo G ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Bile salts; Hepatocellular lysis; Plasma membrane; Taurochenodeoxycholate; Tauroursodeoxycholate

Indexed keywords

BILE SALT; CHOLESTEROL; DIGITONIN; LACTATE DEHYDROGENASE; TAUROCHENODEOXYCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; TRITON X 100;

ANIMAL CELL; ARTICLE; BILAYER MEMBRANE; BIOACCUMULATION; CELL ISOLATION; CELL PROTECTION; CHOLESTASIS; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; DRUG MECHANISM; ENZYME RELEASE; LIVER CELL MEMBRANE; MALE; MEMBRANE STABILIZATION; MICELLE; NONHUMAN; PHASE TRANSITION; RAT;

ANIMALS; CELL DEATH; CELL MEMBRANE; DETERGENTS; DIGITONIN; HEPATOCYTES; LIPID BILAYERS; MALE; MICELLES; OSMOSIS; PHASE TRANSITION; POLYETHYLENE GLYCOLS; RATS; SOLUBILITY; TAUROCHENODEOXYCHOLIC ACID;

EID: 78149468784     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.08.004     Document Type: Article

References (44)

1. Poupon R., Poupon R.E. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol. Ther. 1995, 66:1-15.
2. James O.F. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. J. Hepatol. 1990, 11:5-8.
3. de Caestecker J.S., Jazrawi R.P., Petroni M.L., Northfield T.C. Ursodeoxycholic acid in chronic liver disease. Gut 1991, 32:1061-1065.
4. Lebensztejn D.M. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children. Med. Sci. Monit. 2000, 6:632-636.
5. Palma J., Reyes H., Ribalta J., Hernandez I., Sandoval L., Almuna R., Liepins J., Lira F., Sedano M., Silva O., Toha D., Silva J.J. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J. Hepatol. 1997, 27:1022-1028.
6. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:318-328.
7. Roma M.G., Crocenzi F.A., Sanchez Pozzi E.A. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin. Sci. (Lond.) 2008, 114:567-588.
8. Roma M.G., Crocenzi F.A., Mottino A.D. Dynamic localization of hepatocellular transporters in health and disease. World J. Gastroenterol. 2008, 14:6786-6801.
9. Ikegami T., Matsuzaki Y. Ursodeoxycholic acid: mechanism of action and novel clinical applications. Hepatol. Res. 2008, 38:123-131.
10. Attili A.F., Angelico M., Cantafora A., Alvaro D., Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med. Hypotheses 1986, 19:57-69.
11. Benz C., Angermuller S., Tox U., Kloters-Plachky P., Riedel H.D., Sauer P., Stremmel W., Stiehl A. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J. Hepatol. 1998, 28:99-106.
12. Amaral J.D., Viana R.J., Ramalho R.M., Steer C.J., Rodrigues C.M. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 2009, 50:1721-1734.
13. Leuschner U., Fischer H., Kurtz W., Guldutuna S., Hubner K., Hellstern A., Gatzen M., Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989, 97:1268-1274.
14. Heuman D.M., Bajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 1994, 106:1333-1341.
15. Leuschner U., Guldutuna S., Bhatti S., Elze A., Imhof M., You T., Zimmer G. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. Ital. J. Gastroenterol. 1995, 27:376-377.
16. Guldutuna S., Deisinger B., Weiss A., Freisleben H.J., Zimmer G., Sipos P., Leuschner U. Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles. Biochim. Biophys. Acta 1997, 1326:265-274.
17. Zhou Y., Doyen R., Lichtenberger L.M. The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid. Biochim. Biophys. Acta 2009, 1788:507-513.
18. Heuman D.M., Bajaj R.S., Lin Q. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. J. Lipid Res. 1996, 37:562-573.
19. Mazzone A., Tietz P., Jefferson J., Pagano R., LaRusso N.F. Isolation and characterization of lipid microdomains from apical and basolateral plasma membranes of rat hepatocytes. Hepatology 2006, 43:287-296.
20. Meier P.J., Sztul E.S., Reuben A., Boyer J.L. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J. Cell Biol. 1984, 98:991-1000.
21. Lowry O.H., Rosembrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
22. Erlejman A.G., Verstraeten S.V., Fraga C.G., Oteiza P.I. The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects. Free Radic. Res. 2004, 38:1311-1320.
23. Domecq A., Disalvo E.A., Bernik D.L., Florenzano F., Politi M.J. A stability test of liposome preparations using steady-state fluorescent measurements. Drug Deliv. 2001, 8:155-160.
24. MacDonald R.I. Characteristics of self-quenching of the fluorescence of lipid-conjugated rhodamine in membranes. J. Biol. Chem. 1990, 265:13533-13539.
25. Berry M.N., Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J. Cell Biol. 1969, 43:506-520.
26. Borgognone M., Perez L.M., Basiglio C.L., Ochoa J.E., Roma M.G. Signaling modulation of bile salt-induced necrosis in isolated rat hepatocytes. Toxicol. Sci. 2005, 83:114-125.
27. Baur H., Kasperek S., Pfaff E. Criteria of viability of isolated liver cells. Hoppe Seylers Z. Physiol. Chem. 1975, 356:827-838.
28. Ramellini G., Meldolesi J. Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes. Arzneimittelforschung 1976, 26:69-73.
29. Heuman D.M., Mills A.S., McCall J., Hylemon P.B., Pandak W.M., Vlahcevic Z.R. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 1991, 100:203-211.
30. Heuman D.M., Pandak W.M., Hylemon P.B., Vlahcevic Z.R. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991, 14:920-926.
31. Ohiwa T., Katagiri K., Hoshino M., Hayakawa T., Nakai T. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. Hepatology 1993, 17:470-476.
32. Krahenbuhl S., Fischer S., Talos C., Reichen J. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. Hepatology 1994, 20:1595-1601.
33. Rodrigues C.M., Fan G., Ma X., Kren B.T., Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 1998, 101:2790-2799.
34. Sokol R.J., Devereaux M., Khandwala R., O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993, 17:869-881.
35. Sagawa H., Tazuma S., Kajiyama G. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am. J. Physiol. 1993, 264:G835-G839.
36. Chen J., Mandel L.J. Role of water and electrolyte influxes in anoxic plasma membrane disruption. Am. J. Physiol. 1997, 273:C1341-C1348.
37. Heerklotz H. Interactions of surfactants with lipid membranes. Q. Rev. Biophys. 2008, 41:205-264.
38. Basiglio C.L., Sanchez Pozzi E.J., Mottino A.D., Roma M.G. Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis. Chem. Biol. Interact. 2009, 179:297-303.
39. Amigo L., Mendoza H., Zanlungo S., Miquel J.F., Rigotti A., Gonzalez S., Nervi F. Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt-induced hepatic damage. J. Lipid Res. 1999, 40:533-542.
40. El K.K., Morandat S. Cholesterol modulation of membrane resistance to Triton X-100 explored by atomic force microscopy. Biochim. Biophys. Acta 2007, 1768:2300-2309.
41. Katz J., Wals P.A. Studies with digitonin-treated rat hepatocytes (nude cells). J. Cell Biochem. 1985, 28:207-228.
42. Nishikawa M., Nojima S., Akiyama T., Sankawa U., Inoue K. Interaction of digitonin and its analogs with membrane cholesterol. J. Biochem. 1984, 96:1231-1239.
43. Tietz P.S., Thistle J.L., Miller L.J., LaRusso N.F. Development and validation of a method for measuring the glycine and taurine conjugates of bile acids in bile by high-performance liquid chromatography. J. Chromatogr. 1984, 336:249-257.
44. Paila Y.D., Pucadyil T.J., Chattopadhyay A. The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin 1A receptor. Mol. Membr. Biol. 2005, 22:241-249.